X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
cardiac & cardiovascular systems (9) 9
humans (8) 8
cardiology (7) 7
aged (6) 6
female (6) 6
male (6) 6
middle aged (6) 6
drug-eluting stents (5) 5
time factors (5) 5
abridged index medicus (4) 4
acute myocardial-infarction (4) 4
cardiovascular (4) 4
cardiovascular disease (4) 4
care and treatment (4) 4
clopidogrel (4) 4
coronary artery disease (4) 4
coronary vessels (4) 4
internal medicine (4) 4
risk factors (4) 4
stents (4) 4
treatment outcome (4) 4
usage (4) 4
acute coronary syndrome - mortality (3) 3
acute coronary syndrome - therapy (3) 3
aged, 80 and over (3) 3
aspirin (3) 3
atherosclerosis (3) 3
atherosclerotic plaque (3) 3
guidelines (3) 3
heart (3) 3
intravascular ultrasound (3) 3
medical imaging (3) 3
medical research (3) 3
medicine & public health (3) 3
optical coherence tomography (3) 3
patients (3) 3
percutaneous coronary intervention - adverse effects (3) 3
percutaneous coronary intervention - mortality (3) 3
registries (3) 3
risk assessment (3) 3
switzerland (3) 3
thrombosis (3) 3
acute coronary syndrome - blood (2) 2
acute coronary syndrome - diagnosis (2) 2
analysis (2) 2
angiography (2) 2
anticoagulants - administration & dosage (2) 2
association (2) 2
biology and life sciences (2) 2
coherence (2) 2
coronary artery disease - mortality (2) 2
coronary artery disease - therapy (2) 2
coronary heart disease (2) 2
coronary vessels - pathology (2) 2
diagnosis (2) 2
disease (2) 2
drug administration schedule (2) 2
follow-up studies (2) 2
generalizability (2) 2
heart attacks (2) 2
hemorrhage - chemically induced (2) 2
intervention (2) 2
interventional trial (2) 2
kaplan-meier estimate (2) 2
lipids (2) 2
major adverse cardiac events (2) 2
medical colleges (2) 2
medicine (2) 2
medicine and health sciences (2) 2
medicine, experimental (2) 2
mortality (2) 2
multidisciplinary sciences (2) 2
myocardial infarction (2) 2
myocardial infarction - etiology (2) 2
myocardial-infarction (2) 2
nonculprit plaque (2) 2
patient outcomes (2) 2
platelet aggregation inhibitors - administration & dosage (2) 2
platelet aggregation inhibitors - adverse effects (2) 2
prasugrel (2) 2
proportional hazards models (2) 2
research (2) 2
research and analysis methods (2) 2
science (2) 2
severity of illness index (2) 2
stenosis (2) 2
stent (2) 2
therapy (2) 2
tomography, optical coherence - methods (2) 2
ultrasonic imaging (2) 2
acquisition (1) 1
acute coronary syndrome (1) 1
acute coronary syndrome - diagnostic imaging (1) 1
acute coronary syndrome - physiopathology (1) 1
acute coronary syndromes (1) 1
acute migraine treatment (1) 1
adherence (1) 1
administration, oral (1) 1
age (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1025 - 1034
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 14, pp. 1473 - 1483
Abstract Objectives The aim of this study was to compare clinical outcomes in relation to the duration of triple antithrombotic therapy (TAT) among patients... 
Cardiovascular | coronary intervention | bleeding | antiplatelet | anticoagulation | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULANT-THERAPY | ASPIRIN | ATRIAL-FIBRILLATION PATIENTS | CONSENSUS DOCUMENT | DEFINITIONS | CLOPIDOGREL | DUAL ANTIPLATELET THERAPY | ELUTING STENT IMPLANTATION | Multivariate Analysis | Anticoagulants - administration & dosage | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Coronary Artery Disease - blood | Fibrinolytic Agents - adverse effects | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Female | Registries | Retrospective Studies | Drug Therapy, Combination | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Drug Administration Schedule | Administration, Oral | Risk Factors | Acute Coronary Syndrome - diagnostic imaging | Proportional Hazards Models | Treatment Outcome | Coronary Artery Disease - mortality | Anticoagulants - adverse effects | Chi-Square Distribution | Switzerland | Acute Coronary Syndrome - blood | Coronary Artery Disease - diagnostic imaging | Stroke - etiology | Coronary Artery Disease - therapy | Acute Coronary Syndrome - therapy | Aged | Coronary Thrombosis - etiology | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 163, Issue 5, pp. 876 - 886.e2
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2017, Volume 69, Issue 20, pp. 2502 - 2513
Background Lipid-rich plaque (LRP) is thought to be a precursor to cardiac events. However, its clinical significance in coronary arteries has never been... 
coronary artery disease | major adverse cardiac events | atherosclerotic plaque | nonculprit plaque | CORONARY ATHEROSCLEROTIC PLAQUE | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | DEATH | FEATURES | ATORVASTATIN | THERAPY | FREQUENCY | DISEASE | ACUTE MYOCARDIAL-INFARCTION | THIN-CAP FIBROATHEROMA | Coronary Vessels - diagnostic imaging | Plaque, Atherosclerotic - diagnostic imaging | Predictive Value of Tests | Recurrence | Risk Assessment - methods | Myocardial Infarction - epidemiology | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Acute Coronary Syndrome - physiopathology | Lipids | Male | Long Term Adverse Effects - physiopathology | Percutaneous Coronary Intervention - methods | Female | Myocardial Infarction - physiopathology | Plaque, Atherosclerotic - pathology | Myocardial Infarction - diagnosis | Severity of Illness Index | Coronary Vessels - pathology | Kaplan-Meier Estimate | Tomography, Optical Coherence - methods | Long Term Adverse Effects - diagnosis | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - therapy | Percutaneous Coronary Intervention - statistics & numerical data | Aged | Long Term Adverse Effects - epidemiology | Tomography | Heart | Myocardial infarction | Intervention | Medical imaging | Target recognition | Angioplasty | Coronary artery | Stenosis | Cardiovascular disease | Risk | Patients | Arteries | Confidence intervals | Optical Coherence Tomography | Ischemia | Coronary vessels | Coherence | Infarction | Cardiology | Heart diseases
Journal Article
Clinical Research in Cardiology, ISSN 1861-0684, 9/2016, Volume 105, Issue 9, pp. 744 - 754
We sought to systematically evaluate the external validity of a contemporary randomized controlled stent trial (BIOSCIENCE).Baseline characteristics and... 
Interventional trial | Medicine & Public Health | Generalizability | Cardiology | Drug-eluting stents
Journal Article
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 05/2018, Volume 11, Issue 5, pp. e006132 - e006132
BACKGROUND—Although ticagrelor has improved clinical outcomes among patients with acute coronary syndrome compared with clopidogrel, adherence to this new... 
clopidogrel | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTAGONIST | tertiary care centers | dyspnea | ticagrelor | ASPIRIN | ADHERENCE | percutaneous coronary intervention | THERAPY | TOLERABILITY | PREDICTORS | ANTIPLATELET TREATMENT | PRASUGREL | INSIGHTS | Dyspnea - chemically induced | Purinergic P2Y Receptor Antagonists - administration & dosage | Anticoagulants - administration & dosage | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Clopidogrel - administration & dosage | Practice Patterns, Physicians | Purinergic P2Y Receptor Antagonists - adverse effects | Ticagrelor - adverse effects | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Ticagrelor - administration & dosage | Female | Registries | Prasugrel Hydrochloride - administration & dosage | Drug Substitution - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Drug Substitution - mortality | Tertiary Care Centers | Drug Administration Schedule | Treatment Outcome | Prasugrel Hydrochloride - adverse effects | Switzerland | Acute Coronary Syndrome - blood | Medication Adherence | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - therapy | Aged | Clopidogrel - adverse effects | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Care and treatment | Usage | Clopidogrel | Acute coronary syndrome | Cardiovascular diseases | Comparative analysis | Ticagrelor | Risk factors
Journal Article
by Melander, A and Olsson, J and Lindberg, G and Salzman, A and Howard, T and Stang, P and Lydick, E and Emslie-Smith, A and Boyle, D I. R and Evans, J M. M and Macdonald, T M and Bain, J and Sullivan, F and Juhl, C and Pørksen, N and Sturis, J and Hollingdal, M and Pincus, S and Veldhuis, J and Dejgaard, A and Schmitz, O and Kristensen, J S and Frandsen, K B and Bayer, Th and Müller, P and Dunning, B E and Paladini, S and Gutierrez, C and Deacon, R and Valentin, M and Grunberger, G and Weston, W M and Patwardhan, R and Rappaport, E B and Sargeant, L A and Wareham, N J and Khaw, K T and Zethelius, Björn and Lithell, Hans and Hales, C Nicholas and Berne, Christian and Lakka, H.-M and Oksanen, L and Tuomainen, T.-P and Kontula, K and Salonen, J T and Dekker, J M and de Boks, P and de Vegt, F and Stehouwer, C D. A and Nijpels, G and Bouter, L M and Heine, R J and Bruno, G and Cavallo-Perin, P and Bargero, G and D’Errico, N and Borra, M and Macchia, G and Pagano, G and Newton, R W and Ruta, D A and New, J P and Wallace, C and Roxburgh, M A and Young, R J and Vaughan, N J. A and Elliott, P and Brennan, G and Devers, M and MacAlpine, R and Steinke, D and Lawson, D H and Decallonne, B and Casteels, K and Gysemans, C and Bouillon, R and Mathieu, C and Linn, Thomas and Strate, Christine and Schneider, Kerstin and Funda, D P and Jirsa Jr, M and Kozáková, H and Kaas, A and Kofronová, O and Tlaskalová-Hogenová, H and Buschard, K and Wanka, H and Hartmann, A and Kuttler, B and Rasmussen, S B and Sørensen, T S and Markholst, H and Petersen, J S and Karounos, D and Dyrberg, T and Mabley, J G and Haskó, G and Szabó, C and ... and IMDIAB Study Group and Osaka IDDM Study Group and European Group for the Study of Insulin Resistance (EGIR) and Screen-Pol Study Group and Northern Diabetic Pregnancy Survey and Brazilian Gestational Diabetes Study Group and UK Prospective Diabetes Study Group and Hungarian HbA1c Screening Study Group and Croatian Study Group for Diabetic Amyotrophy and EURODIAB IDDM Study Group and Neuropathy Study Group of the Italian Society of the Study of Diabetes and Pittsburgh Epidemiology of Diabetes Complications (EDC) Study and HOE 901/3003 study group and German Working Group on Quality Control and Turkish Diabetes Epidemiology Group and Mauritian NCD group and D.I.O.R. study group and Lithuanian Collaborative Group for the Epidemiology of Diabetes and DARTS/MEMO Collaboration and Cerivastatin/Bezafibrate Latin America Study Group and Pramlintide Type 1 Study Group and Non-Invasive Task Force and Childhood Diabetes in Finland Study Group and German Pediat. Working Group and EURODIAB Complications Study Group and Hvidøre Study group on Childhood Diabetes and EURODIAB Prospective Complications Study (PCS) Group and WHO/IDF Patient Empowerment Workshop and AD Morris for the DARTS/MEMO Collaboration and Pramlintide Type 2 Study Group and Finnish Diabetes Prevention Study Group and Service of internal medecine - diabetologia - vascular diseases and UKPDS Group and IGT Research Group and DAIS Project Group and KANWU study group and Cerivastatin Combination Therapy Study Group and GENEDIAB Study Group and TARDIS Steering Committee and UK centres and Rosiglitazone Study Group and GEDEC study group and HIDM investigators and US Study Group of Insulin Glargine in Type 2 DM and European Insulin Aspart Study Group and The TARDIS Steering Committee and UK centres and The Turkish Diabetes Epidemiology Group and The EURODIAB Prospective Complications Study (PCS) Group and The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study and The Finnish Diabetes Prevention Study Group
Diabetologia, ISSN 0012-186X, 8/1999, Volume 42, Issue S1, pp. A1 - A330
Journal Article
Acta Cardiologica, ISSN 0001-5385, 07/2019, Volume 74, Issue 4, pp. 341 - 349
Background: The outcome of patients undergoing percutaneous coronary interventions (PCIs) varies considerably. Several ECG parameters have recently emerged (PQ... 
mortality | QT interval | Coronary artery disease | electrocardiography | CARDIAC & CARDIOVASCULAR SYSTEMS | AMERICAN-COLLEGE | QT-INTERVAL | ATRIAL-FIBRILLATION | HEART-DISEASE | PR INTERVAL | EARLY REPOLARIZATION | ACUTE MYOCARDIAL-INFARCTION | SUDDEN CARDIAC DEATH | OUTCOMES | ASSOCIATION
Journal Article